1996
DOI: 10.1016/0149-7634(95)00037-f
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms of sickness-induced decreases in food-motivated behavior

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

4
58
0
3

Year Published

1998
1998
2013
2013

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 158 publications
(66 citation statements)
references
References 27 publications
4
58
0
3
Order By: Relevance
“…Current findings thus support the association of mutation status with depression but do not rule out an association of mutation status with the induction of sickness behavior. Future work should test the role of TGF-␣ in concert with inflammatory cytokines that have been implicated in sickness behavior [45][46][47].…”
Section: Discussionmentioning
confidence: 99%
“…Current findings thus support the association of mutation status with depression but do not rule out an association of mutation status with the induction of sickness behavior. Future work should test the role of TGF-␣ in concert with inflammatory cytokines that have been implicated in sickness behavior [45][46][47].…”
Section: Discussionmentioning
confidence: 99%
“…Although peripheral IL-1β and IL-6 responses to LPS did not differ between LD and SD rats, plasma TNFα concentrations were approximately two-fold higher in LD relative to SD rats 2 h after LPS treatment, matching the time course of the onset of exacerbated sickness behaviors in LD rats. Systemic administration of TNFα decreases social exploration in rats and mice (Bluthe et al, 1992;Bluthe et al, 1994) and is also sufficient to suppress feeding behavior under various paradigms (Kent et al, 1996;Plata-Salaman, 1999). TNFα, acting through the TNFR1 and TNFR2 receptor subtypes (Simen et al, 2006), is an important mediator of changes in ingestive behavior and behavioral depression that contribute to pathophysiology of LPS-induced sickness behavior .…”
Section: Discussionmentioning
confidence: 99%
“…Likewise, serum levels of proinflammatory interleukins IL-1b, IL-6, and TNF-a are elevated in depressed patients (Maes, 1999;Tuglu et al, 2003). Conversely, therapeutic treatments with proinflammatory cytokines result in 'sickness behavior' that is similar in many respects to depression, with decreased appetite, anorexia, weight loss, fatigue, loss of libido, sleep disturbances, and reduced social contact (Kent et al, 1996;Yirmiya et al, 2000;Dantzer, 2001), and depression is frequently observed in association with peripheral inflammatory cytokine activation in a number of medical conditions including viral infections, rheumatoid arthritis, cancer, and neurodegenerative diseases (Meijer et al, 1988;Hall and Smith, 1996;Yirmiya et al, 1999;Pollak et al, 2000). Additionally, in human volunteers, depression, anxiety, and memory impairment are associated with immune activation by the bacterial endotoxin, lipopolysaccharide, and are correlated with serum IL-1b and TNF-a levels induced by that treatment (Yirmiya et al, 2000).…”
Section: Introductionmentioning
confidence: 99%